21598111000001102: Xalkori 200mg capsules (Pfizer Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Xalkori 200mg capsules (Pfizer Ltd)
• \UK product\Virtual medicinal product\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \UK product\Virtual therapeutic moiety\Crizotinib\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \UK product\Virtual therapeutic moiety\Crizotinib\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \UK product\Trade family\Xalkori\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing crizotinib\Crizotinib\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing crizotinib\Crizotinib\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing crizotinib\Product containing crizotinib in oral dose form (medicinal product form)\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing crizotinib\Crizotinib\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing crizotinib\Crizotinib\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing crizotinib\Product containing crizotinib in oral dose form (medicinal product form)\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing crizotinib\Crizotinib\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing crizotinib\Crizotinib\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing crizotinib\Product containing crizotinib in oral dose form (medicinal product form)\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing crizotinib in oral dose form (medicinal product form)\Product containing only crizotinib in oral dose form (medicinal product form)\Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule\Xalkori 200mg capsules (Pfizer Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
71609301000001113	Xalkori 200mg capsules (Pfizer Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
71609401000001117	Xalkori 200mg capsules (Pfizer Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start